DAVID RODRIGUEZ: Open Payments
NPI 1659882538 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 29 payments from 8 companies in 2025. Trend: 2023 $415 · 2024 $309 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $271 |
| AstraZeneca Pharmaceuticals LP | 3 | $241 |
| Fresenius USA Marketing, Inc. | 8 | $198 |
| Lilly USA, LLC | 4 | $179 |
| Amgen Inc. | 2 | $135 |
| Travere Therapeutics, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
Products named: Kerendia, VELPHORO, ZEPBOUND, TAVNEOS, AIRSUPRA, BREZTRI, MOUNJARO, JYNARQUE.
Industry payments across TX — which companies pay providers there.
